Secondary Cytoreduction Does Not Improve Survival in Recurrent Ovarian Cancer
Secondary cytoreduction followed by chemotherapy was not found to improve overall survival compared with chemotherapy alone in patients with platinum-sensitive recurrent ovarian cancer.
Source: OncLive